Determination of the Cannabinoid CB1 Receptor’s Positive Allosteric Modulator Binding Site through Mutagenesis Studies
Positive allosteric modulators (PAMs) of the cannabinoid CB1 receptor (CB<sub>1</sub>) offer potential therapeutic advantages in the treatment of neuropathic pain and addiction by avoiding the adverse effects associated with orthosteric CB<sub>1</sub> activation. Here, molecular modeling and mutagen...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2024-01-01
|
| Reeks: | Pharmaceuticals |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/1424-8247/17/2/154 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|